_id,doi,title
6088,10.1021/acs.molpharmaceut.8b01217,Inhibition of ABCB1 and ABCG2 at the mouse blood-brain barrier with marketed drugs to improve brain delivery of the model ABCB1/ABCG2 substrate [11C]erlotinib